Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summary.
Journal: Neurodegenerative disease management
Published: July 26, 2024
Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis.
Journal: Annals of neurology
Published: March 21, 2024
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 31, 2023
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
Journal: Advances in therapy
Published: November 19, 2021
The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: November 15, 2021
Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a.
Journal: Multiple sclerosis and related disorders
Published: April 13, 2021
Encephalitis and Myelitis in a Young Woman: Overlap Syndrome, Thyroiditis, and Occult Tumor From the National Multiple Sclerosis Society Case Conference Proceedings.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 29, 2021
Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndrome.
Journal: Journal of neurology
Published: March 09, 2021
Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study.
Journal: Therapeutic advances in neurological disorders
Published: September 23, 2020
Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS.
Journal: Multiple sclerosis and related disorders
Published: August 05, 2020
Inflammatory colitis associated with Teriflunomide.
Journal: Multiple sclerosis and related disorders
Published: July 30, 2020
COVID-19 in MS: Initial observations from the Pacific Northwest.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 14, 2020
Last Updated: 09/26/2026